Aiming to do for epilepsy what it has done for migraine, New Haven’s Biohaven announced data that show progress on a new drug for the neurological ailment with fewer side effects … more
The FDA has approved a quick-acting nasal spray for acute treatment of migraine. The spray was developed by Biohaven and recently acquired by Pfizer … more